前列腺癌的内分泌治疗
Endocrine therapy of prostate cancer.
作者信息
Bare R L, Torti F M
机构信息
Department of Urology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157-1094, USA.
出版信息
Cancer Treat Res. 1998;94:69-87. doi: 10.1007/978-1-4615-6189-7_5.
PMID:9587683
Abstract
Endocrine therapy is effective treatment for patients with metastatic prostate cancer. Most patients will benefit from androgen withdrawal in terms of symptomatic relief and delay in progression of diseases. It does not, however, cure patients with metastatic prostate cancer. This finding emphasizes the need for the development of effective nonendocrine therapies.
摘要
内分泌治疗是转移性前列腺癌患者的有效治疗方法。大多数患者将从雄激素剥夺中受益，在症状缓解和疾病进展延迟方面。然而，它并不能治愈转移性前列腺癌患者。这一发现强调了开发有效的非内分泌疗法的必要性。
相似文献
1
Endocrine therapy of prostate cancer.
Cancer Treat Res. 1998;94:69-87. doi: 10.1007/978-1-4615-6189-7_5.
2
Hormone therapy in advanced prostate cancer.
Front Radiat Ther Oncol. 2002;36:49-65. doi: 10.1159/000061329.
3
Adjuvant hormone therapy in locally advanced and localized prostate cancer: three EORTC trials.
Front Radiat Ther Oncol. 2002;36:81-6. doi: 10.1159/000061332.
4
Hormone therapy of prostatic bone metastases.
Adv Exp Med Biol. 1992;324:305-16. doi: 10.1007/978-1-4615-3398-6_33.
5
Role of secondary hormonal therapy in the management of recurrent prostate cancer.
Urology. 2003 Dec 29;62 Suppl 1:87-94. doi: 10.1016/j.urology.2003.10.002.
6
Intermittent androgen ablation as a treatment for prostate cancer.
Front Radiat Ther Oncol. 2002;36:66-71. doi: 10.1159/000061330.
7
[Hormono-radiotherapy of non-metastatic prostate cancers].
Cancer Radiother. 2002 May;6(3):175-82. doi: 10.1016/s1278-3218(02)00158-0.
8
Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer.
Urology. 2003 Dec 29;62 Suppl 1:79-86. doi: 10.1016/j.urology.2003.09.002.
9
Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach.
Expert Opin Investig Drugs. 2006 Jul;15(7):795-804. doi: 10.1517/13543784.15.7.795.
10
Endocrine treatment of prostate cancer: standard treatment and new perspectives.
In Vivo. 1993 Sep-Oct;7(5):423-4.
引用本文的文献
1
Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment.
Steroids. 2013 Jun;78(6):538-41. doi: 10.1016/j.steroids.2013.01.005. Epub 2013 Feb 1.
2
Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis.
Oncogene. 2005 Aug 11;24(34):5375-83. doi: 10.1038/sj.onc.1208684.
Zotero 插件